Differential Changes in Striatal Projection Neurons in R6/2 Transgenic Mice for Huntington's Disease

by Z. Sun, N. Del Mar, C. Meade, D. Goldowitz, A. Reiner
Published 2002-12-01

The group 2 metabotropic glutamate receptor agonist LY379268 rescues neuronal, neurochemical and motor abnormalities in R6/2 Huntington's disease mice

by A. Reiner, D.C. Lafferty, H.B. Wang, N. Del Mar, Y.P. Deng
Published 2012-07-01

Effect of early embryonic deletion of huntingtin from pyramidal neurons on the development and long-term survival of neurons in cerebral cortex and striatum

by I. Dragatsis, P. Dietrich, H. Ren, Y.P. Deng, N. Del Mar, H.B. Wang, I.M. Johnson, K.R. Jones, A. Reiner
Published 2018-03-01

CAG repeat lengths ≥335 attenuate the phenotype in the R6/2 Huntington's disease transgenic mouse

by I. Dragatsis, D. Goldowitz, N. Del Mar, Y.P. Deng, C.A. Meade, Li Liu, Z. Sun, P. Dietrich, J. Yue, A. Reiner
Published 2009-03-01

Increased calbindin-D28k immunoreactivity in striatal projection neurons of R6/2 Huntington's disease transgenic mice

by Z. Sun, H.B. Wang, Y.P. Deng, W.L. Lei, J.P. Xie, C.A. Meade, N. Del Mar, D. Goldowitz, A. Reiner
Published 2005-12-01